Abstract Alzheimers disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and hallmark neuropathological features, including extracellular amyloid- (A) plaques and intracellular neurofibrillary tangles formed by hyperphosphorylated tau
[1] This phenomenon appears to be an indirect consequence of the medication's primary therapeutic effects rather than a direct pharmacological action on temperature regulation
Selection of medication type, including brand-name or compounded formulations
The percentage of patients who discontinued due to ineffective therapy was 5.4% in the liraglutide injection 1.8 mg + metformin treatment group, 3.3% in the liraglutide injection 1.2 mg + metformin treatment group, 23.8% in the placebo + metformin treatment group, and 3.7% in the glimepiride + metformin treated group
GLP-1 receptor agonists are drugs that mimic this hormone to increase insulin secretion, slow gastric emptying, and signal satiety to the brain
Dihexa enhances HGF binding to c-Met rather than mimicking HGF directlyacting as a positive allosteric modulator